| Inosine to increase serum and cerebrospinal fluid urate in Parkinson disease: a randomized clinical trial MA Schwarzschild, A Ascherio, MF Beal, ME Cudkowicz, GC Curhan, ... JAMA neurology 71 (2), 141-150, 2014 | 187 | 2014 |
| Disrupted and transgenic urate oxidase alter urate and dopaminergic neurodegeneration X Chen, TC Burdett, CA Desjardins, R Logan, S Cipriani, Y Xu, ... Proceedings of the National Academy of Sciences 110 (1), 300-305, 2013 | 127 | 2013 |
| Optogenetic restoration of disrupted slow oscillations halts amyloid deposition and restores calcium homeostasis in an animal model of Alzheimer’s disease KV Kastanenka, SS Hou, N Shakerdge, R Logan, D Feng, S Wegmann, ... PloS one 12 (1), e0170275, 2017 | 97 | 2017 |
| Neuroprotective effects of urate are mediated by augmenting astrocytic glutathione synthesis and release R Bakshi, H Zhang, R Logan, I Joshi, Y Xu, X Chen, MA Schwarzschild Neurobiology of disease 82, 574-579, 2015 | 58 | 2015 |
| The melanoma‐linked “redhead” MC1R influences dopaminergic neuron survival X Chen, H Chen, W Cai, M Maguire, B Ya, F Zuo, R Logan, H Li, ... Annals of neurology 81 (3), 395-406, 2017 | 53 | 2017 |
| Higher urate in LRRK2 mutation carriers resistant to Parkinson disease R Bakshi, EA Macklin, R Logan, MM Zorlu, N Xia, GF Crotty, E Zhang, ... Annals of Neurology 85 (4), 593-599, 2019 | 48 | 2019 |
| Frequency-dependent exacerbation of Alzheimer’s disease neuropathophysiology KV Kastanenka, M Calvo-Rodriguez, SS Hou, H Zhou, S Takeda, ... Scientific reports 9 (1), 8964, 2019 | 47 | 2019 |
| Oral I nosine P ersistently E levates P lasma antioxidant capacity in P arkinson's disease S Bhattacharyya, R Bakshi, R Logan, A Ascherio, EA Macklin, ... Movement Disorders 31 (3), 417-421, 2016 | 41 | 2016 |
| Sex differences by design and outcome in the Safety of Urate Elevation in PD (SURE-PD) trial MA Schwarzschild, EA Macklin, R Bakshi, S Battacharyya, R Logan, ... Neurology 93 (14), e1328-e1338, 2019 | 38 | 2019 |
| Deep Convolutional Neural Networks With Ensemble Learning and Generative Adversarial Networks for Alzheimer’s Disease Image Data Classification GAMSJ Logan R, Williams BG, Ferreira da Silva M, Indani A, Schcolnicov N Frontiers in Aging Neuroscience 13 (720226), 2021 | 36 | 2021 |
| Efficient determination of purine metabolites in brain tissue and serum by high‐performance liquid chromatography with electrochemical and UV detection TC Burdett, CA Desjardins, R Logan, NR McFarland, X Chen, ... Biomedical Chromatography 27 (1), 122-129, 2013 | 33 | 2013 |
| Genetic diversity of axon degenerative mechanisms in models of Parkinson's disease MF Peters, Owen M., Alexandra Weiss, Jake Metterville, Lina Song, Robert ... Neurobiology of Disease 155 (105368), 2021 | 19 | 2021 |
| Neuroglial Senescence, α-Synucleinopathy, and the Therapeutic Potential of Senolytics in Parkinson’s Disease S Miller, C Campbell, H Jimenez-Corea, GH Wu, R Logan Frontiers in Neuroscience 16, 824191, 2022 | 15 | 2022 |
| Dissociation between urate and blood pressure in mice and in people with early Parkinson's disease X Chen, CC Umeh, RE Tainsh, DD Feng, M Maguire, F Zuo, M Rahimian, ... EBioMedicine 37, 259-268, 2018 | 12 | 2018 |
| 3GOLD: optimized Levenshtein distance for clustering third-generation sequencing data R Logan, Z Fleischmann, S Annis, AW Wehe, JL Tilly, DC Woods, ... BMC bioinformatics 23 (1), 95, 2022 | 9 | 2022 |
| Purines in Parkinson’s: Adenosine A2A Receptors and Urate as Targets for Neuroprotection R Bakshi, R Logan, MA Schwarzschild The Adenosinergic System: A Non-Dopaminergic Target in Parkinson’s Disease …, 2015 | 8 | 2015 |
| Clinical characteristics of the first known cases of death caused by COVID-19 pneumonia SMH Fan-Zhen Kong, Yi Wang, Mei-Xia Wang, Qing-Zhang Cheng, Robert Logan ... Aging 12 (22), 22405-22412, 2020 | 5 | 2020 |
| LUCS: a high-resolution nucleic acid sequencing tool for accurate long-read analysis of individual DNA molecules S Annis, Z Fleischmann, R Logan, Z Mullin-Bernstein, M Franco, J Saürich, ... Aging (Albany NY) 12 (8), 7603, 2020 | 3 | 2020 |
| The Future of Artificial Intelligence for Alzheimer’s Disease Diagnostics R Logan, SS Zerbey, SJ Miller Advancements in Alzheimer's Disease 10, 53-59, 2021 | 2 | 2021 |
| Oral Inosine Persistently Elevates Plasma Antioxidant Capacity in Early Parkinson’s Disease (S37. 009) S Bhattacharyya, R Bakshi, R Logan, A Ascherio, E Macklin, ... Neurology 82 (10_supplement), S37. 009, 2014 | 2 | 2014 |
